Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (467)	12/28/1997 12:55:00 PM
From: sam	Read Replies (1) \| Respond to of 834

TXB did not invent novastan. They never claimed they did. They licensed the compound from Genentech and Mitsubishi Chemical. And they are developing it. In this regard, I do not believe development to be a relative term. It means taking a compound from the invention stage to the marketing stage. Stage I, II, and III trials, FDA management, worldwide development, manufacturing issues, etc... Besides SEC documents and U.S. Patent filings, I find the following site to be quite helpful: recap.com Not only is the difference between "develper" and "marketer" etc. defined, but if you search novastan (under clinical trials) you will learn from whom TXB licensed novastan. Hope this helps.